WBA Dividends
Walgreens Boots Alliance, Inc. (WBA) pays $1.00 in dividends per share, with a current dividend yield of N/A.
WBA Dividend Summary
$1.00
N/A
Consecutive Years
0
Most Recent Ex-Date
Nov 18, 2024
Most Recent Payment
Dec 12, 2024
WBA Dividends per Share (Nominal History)
View full nominal table listThis step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.
WBA Dividends CAGR Chart
Walgreens Boots Alliance, Inc. (WBA)
Annual Dividend History
| Year | Dividend/Share | YoY Growth |
|---|---|---|
| 2024 | $1.00 | -47.92% |
| 2023 | $1.92 | +0.26% |
| 2022 | $1.92 | +1.32% |
| 2021 | $1.89 | +2.16% |
| 2020 | $1.85 | +3.06% |
| 2019 | $1.79 | +6.85% |
| 2018 | $1.68 | +8.39% |
| 2017 | $1.55 | +5.44% |
| 2016 | $1.47 | +5.38% |
| 2015 | $1.40 | +6.90% |
| 2014 | $1.31 | +10.59% |
| 2013 | $1.18 | +18.00% |
| 2012 | $1.00 | +25.00% |
| 2011 | $0.80 | +28.00% |
| 2010 | $0.63 | +25.00% |
| 2009 | $0.50 | +20.48% |
| 2008 | $0.41 | +20.29% |
| 2007 | $0.34 | +21.05% |
| 2006 | $0.29 | +21.28% |
| 2005 | $0.23 | +22.88% |
Quarterly Dividend History
| Quarter | Dividend/Share | YoY Growth |
|---|---|---|
| Q4 2024 | $0.25 | -47.92% |
| Q3 2024 | $0.25 | -47.92% |
| Q2 2024 | $0.25 | -47.92% |
| Q1 2024 | $0.25 | -47.92% |
| Q4 2023 | $0.48 | +0.00% |
| Q3 2023 | $0.48 | +0.00% |
| Q2 2023 | $0.48 | +0.52% |
| Q1 2023 | $0.48 | +0.52% |
| Q4 2022 | $0.48 | +0.52% |
| Q3 2022 | $0.48 | +0.52% |
| Q2 2022 | $0.48 | +2.14% |
| Q1 2022 | $0.48 | +2.14% |
| Q4 2021 | $0.48 | +2.14% |
| Q3 2021 | $0.48 | +2.14% |
| Q2 2021 | $0.47 | +2.19% |
| Q1 2021 | $0.47 | +2.19% |
| Q4 2020 | $0.47 | +2.19% |
| Q3 2020 | $0.47 | +2.19% |
| Q2 2020 | $0.46 | +3.98% |
| Q1 2020 | $0.46 | +3.98% |
| Q4 2019 | $0.46 | +3.98% |
| Q3 2019 | $0.46 | +3.98% |
| Q2 2019 | $0.44 | +10.00% |
| Q1 2019 | $0.44 | +10.00% |
Dividend Yield Metrics
- Current Yield
- N/A
- Average Yield (TTM)
- N/A
- Average Yield (3Y)
- 13.45%
- Forward Yield on Cost (3Y)
- < 3Y history
- Forward Yield on Cost (5Y)
- < 5Y history
- Forward Yield on Cost (10Y)
- < 10Y history
Payout Ratio Analysis
- Payout Ratio (Current)
- N/A
- FCF Payout Ratio
- N/A
- Payout Ratio (3Y Avg)
- 158.58%
- Payout Ratio (5Y Avg)
- 110.45%
- FCF Payout (3Y Avg)
- 430.34%
- FCF Payout (5Y Avg)
- 274.62%
An FCF payout above 100% means dividends exceeded the period's free cash flow, often because of temporarily depressed FCF (one-off capex or working-capital swings) rather than an unfunded dividend. Compare against the earnings payout ratio and the multi-year trend before drawing a conclusion.
Dividend Coverage
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth